| Biotechnology feed | All feeds
To find out how to adjust your browser settings to accept cookies, please click here.
Medscape uses cookies to customize the site based on the information... Abstracts in Hematology and Oncology: Mar 15 2010 9:48PM Matching: fludarabine Find similar documents
Afanasiev, Loree Larratt, Christian H.
Geisler, Marco Montillo, Ilya Zyuzgin, Peter S.
Ganly, Caroline Dartigeas, Andrs Rosta, Jrg... Journal of Clinical Oncology: Mar 3 2010 12:53AM Matching: fludarabine Find similar documents
Wierda,* Thomas J.
Kipps, Ji Mayer, Stephan Stilgenbauer, Cathy D.
Williams, Andrzej Hellmann, Tadeusz Robak, Richard R.
Furman, Peter Hillmen, Marek Trneny, Martin J.S.
Dyer, Swami Padmanabhan, Magdalena Piotrowska, Tomas Kozak, Geoffrey... Journal of Clinical Oncology: Mar 3 2010 12:50AM Matching: fludarabine Find similar documents
and Biogen Idec treatment Rituxan as part of a combination therapy for chronic lymphocytic leukemia.
South San Francisco-based Genentech, a biotech subsidiary of Swiss drug giant Roche Group, said the Food... Houston Business Journal: Feb 20 2010 3:04AM Matching: fludarabine Find similar documents
South San Francisco-based Genentech, a biotech subsidiary of Swiss drug giant Roche Group, said the Food... Business Journal of Jacksonville: Feb 19 2010 8:19PM Matching: fludarabine Find similar documents
22, 2010 (GLOBE NEWSWIRE) -- Summary: GSK and Genmab have received a positive opinion for conditional approval of Arzerra (ofatumumab) in Europe for CLL that is refractory to fludarabine and alemtuzumab.
GlaxoSmithKline (GSK) and... Stockwatch: Jan 22 2010 10:51AM Matching: fludarabine Find similar documents
Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.
All rights reserved. All other trademarks recognized. Copyright 1997-2009 - BioPortfolio Limited.
